Anti-inflammatory drugs lower risk of Alzheimer’s
Non-steroidal anti-inflammatory drugs (NSAIDS) lower the risk of developing Alzheimer’s disease, claim researchers in this week’s BMJ.
The authors identified 15 studies published between 1996 and October 2002 that examined the role of NSAID use in preventing Alzheimer’’s disease. They carried out three separate analyses to quantify the risk of Alzheimer’’s disease in NSAID users and in aspirin users and to determine any influence on duration of use.
Their results show that NSAIDS offer some protection against the development of Alzheimer’’s disease and that the benefits may be greater the longer NSAIDs are used.
They also suggest that aspirin has a protective effect, but this result was not significant, probably because of the small number of studies that specifically evaluated the effects of aspirin.
However, the appropriate dose, duration, and the ratios of risk to benefit are still unclear, they conclude.
Alle Nachrichten aus der Kategorie: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
Material found in house paint may spur technology revolution
Sandia developed new device to more efficiently process information. The development of a new method to make non-volatile computer memory may have unlocked a problem that has been holding back…
Immune protein orchestrates daily rhythm of squid-bacteria symbiotic relationship
Nearly every organism hosts a collection of symbiotic microbes–a microbiome. It is now recognized that microbiomes are major drivers of health in all animals, including humans, and that these symbiotic…